nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—Small Ligand GPCRs—MTNR1B—metabolic syndrome X	0.0539	0.0739	CbGpPWpGaD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—HSD11B1—metabolic syndrome X	0.0481	0.0659	CbGpPWpGaD
Misoprostol—PTGER2—Small Ligand GPCRs—MTNR1B—metabolic syndrome X	0.0443	0.0607	CbGpPWpGaD
Misoprostol—PTGER3—Small Ligand GPCRs—MTNR1B—metabolic syndrome X	0.0409	0.056	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—HSD11B1—metabolic syndrome X	0.0395	0.0541	CbGpPWpGaD
Misoprostol—PTGER4—Small Ligand GPCRs—CNR1—metabolic syndrome X	0.0377	0.0517	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—HSD11B1—metabolic syndrome X	0.0365	0.05	CbGpPWpGaD
Misoprostol—PTGER2—Small Ligand GPCRs—CNR1—metabolic syndrome X	0.031	0.0424	CbGpPWpGaD
Misoprostol—PTGER3—Small Ligand GPCRs—CNR1—metabolic syndrome X	0.0286	0.0392	CbGpPWpGaD
Misoprostol—PTGER4—cardiovascular system—metabolic syndrome X	0.0259	0.187	CbGeAlD
Misoprostol—PTGER4—kidney—metabolic syndrome X	0.0253	0.183	CbGeAlD
Misoprostol—PTGER2—adipose tissue—metabolic syndrome X	0.0232	0.168	CbGeAlD
Misoprostol—PTGER4—adipose tissue—metabolic syndrome X	0.0228	0.165	CbGeAlD
Misoprostol—PTGER3—kidney—metabolic syndrome X	0.0214	0.155	CbGeAlD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—PLA2G4A—metabolic syndrome X	0.0202	0.0277	CbGpPWpGaD
Misoprostol—PTGER3—adipose tissue—metabolic syndrome X	0.0193	0.14	CbGeAlD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—PLA2G4A—metabolic syndrome X	0.0166	0.0227	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—PLA2G4A—metabolic syndrome X	0.0153	0.021	CbGpPWpGaD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—PTGS2—metabolic syndrome X	0.0114	0.0156	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—PTGS2—metabolic syndrome X	0.00935	0.0128	CbGpPWpGaD
Misoprostol—Rigors—Metformin—metabolic syndrome X	0.0092	0.0694	CcSEcCtD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—PTGS2—metabolic syndrome X	0.00863	0.0118	CbGpPWpGaD
Misoprostol—Neuropathy—Metformin—metabolic syndrome X	0.00705	0.0532	CcSEcCtD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.00669	0.00917	CbGpPWpGaD
Misoprostol—Ear pain—Metformin—metabolic syndrome X	0.00639	0.0482	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.00573	0.00786	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.00549	0.00753	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—MTNR1B—metabolic syndrome X	0.00546	0.00749	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.00521	0.00714	CbGpPWpGaD
Misoprostol—Dehydration—Metformin—metabolic syndrome X	0.00507	0.0383	CcSEcCtD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.00507	0.00695	CbGpPWpGaD
Misoprostol—Breast disorder—Metformin—metabolic syndrome X	0.00493	0.0372	CcSEcCtD
Misoprostol—Cramp muscle—Metformin—metabolic syndrome X	0.00491	0.037	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.00471	0.00645	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00468	0.00641	CbGpPWpGaD
Misoprostol—Sweating increased—Metformin—metabolic syndrome X	0.00459	0.0346	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00446	0.00612	CbGpPWpGaD
Misoprostol—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00438	0.033	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00436	0.00598	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.00434	0.00595	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.00428	0.00587	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00423	0.0058	CbGpPWpGaD
Misoprostol—Drowsiness—Metformin—metabolic syndrome X	0.0042	0.0317	CcSEcCtD
Misoprostol—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00412	0.0311	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00401	0.00549	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.00395	0.00541	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00384	0.00527	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CNR1—metabolic syndrome X	0.00382	0.00524	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00367	0.00503	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00358	0.00491	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00355	0.00486	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00348	0.00476	CbGpPWpGaD
Misoprostol—Immune system disorder—Metformin—metabolic syndrome X	0.00341	0.0257	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—HTR2C—metabolic syndrome X	0.0034	0.00466	CbGpPWpGaD
Misoprostol—Chills—Metformin—metabolic syndrome X	0.00338	0.0255	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00338	0.00464	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00331	0.00453	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00329	0.00451	CbGpPWpGaD
Misoprostol—Flatulence—Metformin—metabolic syndrome X	0.00324	0.0244	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—GHRL—metabolic syndrome X	0.00322	0.00442	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00321	0.0044	CbGpPWpGaD
Misoprostol—Muscle spasms—Metformin—metabolic syndrome X	0.00316	0.0238	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00311	0.00426	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CNR1—metabolic syndrome X	0.00305	0.00418	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00304	0.00416	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.00296	0.00406	CbGpPWpGaD
Misoprostol—Syncope—Metformin—metabolic syndrome X	0.00295	0.0222	CcSEcCtD
Misoprostol—Loss of consciousness—Metformin—metabolic syndrome X	0.00289	0.0218	CcSEcCtD
Misoprostol—Hypertension—Metformin—metabolic syndrome X	0.00284	0.0214	CcSEcCtD
Misoprostol—Myalgia—Metformin—metabolic syndrome X	0.0028	0.0211	CcSEcCtD
Misoprostol—Chest pain—Metformin—metabolic syndrome X	0.0028	0.0211	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00279	0.00383	CbGpPWpGaD
Misoprostol—Oedema—Metformin—metabolic syndrome X	0.00268	0.0202	CcSEcCtD
Misoprostol—Infection—Metformin—metabolic syndrome X	0.00266	0.0201	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—GHRL—metabolic syndrome X	0.00265	0.00363	CbGpPWpGaD
Misoprostol—Shock—Metformin—metabolic syndrome X	0.00264	0.0199	CcSEcCtD
Misoprostol—Thrombocytopenia—Metformin—metabolic syndrome X	0.00262	0.0198	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.0026	0.00356	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Metformin—metabolic syndrome X	0.00259	0.0195	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00258	0.00353	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00255	0.0035	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CNR1—metabolic syndrome X	0.00251	0.00344	CbGpPWpGaD
Misoprostol—Hypotension—Metformin—metabolic syndrome X	0.0025	0.0189	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—AGT—metabolic syndrome X	0.00248	0.0034	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00247	0.00338	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—GHRL—metabolic syndrome X	0.00244	0.00335	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00244	0.0184	CcSEcCtD
Misoprostol—Dyspnoea—Metformin—metabolic syndrome X	0.00239	0.018	CcSEcCtD
Misoprostol—Somnolence—Metformin—metabolic syndrome X	0.00238	0.018	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—CCL5—metabolic syndrome X	0.00237	0.00324	CbGpPWpGaD
Misoprostol—Dyspepsia—Metformin—metabolic syndrome X	0.00236	0.0178	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00235	0.00323	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CNR1—metabolic syndrome X	0.00231	0.00317	CbGpPWpGaD
Misoprostol—Fatigue—Metformin—metabolic syndrome X	0.00231	0.0174	CcSEcCtD
Misoprostol—Constipation—Metformin—metabolic syndrome X	0.00229	0.0173	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00224	0.00307	CbGpPWpGaD
Misoprostol—Feeling abnormal—Metformin—metabolic syndrome X	0.00221	0.0167	CcSEcCtD
Misoprostol—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00219	0.0165	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00214	0.00293	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00213	0.00293	CbGpPWpGaD
Misoprostol—Abdominal pain—Metformin—metabolic syndrome X	0.00212	0.016	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00203	0.00278	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—AGT—metabolic syndrome X	0.00198	0.00271	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00197	0.0027	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCL5—metabolic syndrome X	0.00194	0.00266	CbGpPWpGaD
Misoprostol—Asthenia—Metformin—metabolic syndrome X	0.00192	0.0145	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00192	0.00263	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00187	0.00256	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00184	0.00252	CbGpPWpGaD
Misoprostol—Diarrhoea—Metformin—metabolic syndrome X	0.00183	0.0138	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00182	0.0025	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCL5—metabolic syndrome X	0.00179	0.00246	CbGpPWpGaD
Misoprostol—Dizziness—Metformin—metabolic syndrome X	0.00177	0.0134	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00176	0.00241	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00174	0.00239	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00172	0.00236	CbGpPWpGaD
Misoprostol—Vomiting—Metformin—metabolic syndrome X	0.0017	0.0129	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.0017	0.00233	CbGpPWpGaD
Misoprostol—Rash—Metformin—metabolic syndrome X	0.00169	0.0127	CcSEcCtD
Misoprostol—Dermatitis—Metformin—metabolic syndrome X	0.00169	0.0127	CcSEcCtD
Misoprostol—Headache—Metformin—metabolic syndrome X	0.00168	0.0127	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—GHRL—metabolic syndrome X	0.00165	0.00227	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CCL2—metabolic syndrome X	0.00163	0.00223	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—AGT—metabolic syndrome X	0.00163	0.00223	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00162	0.00222	CbGpPWpGaD
Misoprostol—Nausea—Metformin—metabolic syndrome X	0.00159	0.012	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00158	0.00216	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CNR1—metabolic syndrome X	0.00157	0.00215	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—AGT—metabolic syndrome X	0.0015	0.00206	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.0015	0.00205	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HDAC3—metabolic syndrome X	0.00148	0.00203	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00146	0.002	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00143	0.00196	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00142	0.00194	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00138	0.00189	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—GHRL—metabolic syndrome X	0.00136	0.00186	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCL2—metabolic syndrome X	0.00134	0.00183	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00134	0.00183	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00132	0.00181	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00132	0.00181	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00131	0.00179	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TRIB3—metabolic syndrome X	0.00129	0.00177	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—RBP4—metabolic syndrome X	0.00129	0.00177	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CNR1—metabolic syndrome X	0.00129	0.00176	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—GHRL—metabolic syndrome X	0.00125	0.00172	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCL2—metabolic syndrome X	0.00124	0.00169	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HDAC3—metabolic syndrome X	0.00122	0.00167	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CCL5—metabolic syndrome X	0.00121	0.00166	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00121	0.00166	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CNR1—metabolic syndrome X	0.00119	0.00163	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—APOC3—metabolic syndrome X	0.00114	0.00157	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HDAC3—metabolic syndrome X	0.00112	0.00154	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—AGT—metabolic syndrome X	0.00112	0.00153	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.0011	0.0015	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00109	0.00149	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TRIB3—metabolic syndrome X	0.00106	0.00145	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—RBP4—metabolic syndrome X	0.00106	0.00145	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HTR2C—metabolic syndrome X	0.00103	0.00141	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—AGT—metabolic syndrome X	0.00102	0.00139	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00101	0.00139	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MTNR1B—metabolic syndrome X	0.001	0.00137	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CYBA—metabolic syndrome X	0.000998	0.00137	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCL5—metabolic syndrome X	0.000997	0.00137	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000993	0.00136	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TRIB3—metabolic syndrome X	0.000977	0.00134	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—GHRL—metabolic syndrome X	0.000977	0.00134	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—RBP4—metabolic syndrome X	0.000977	0.00134	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—APOC3—metabolic syndrome X	0.000938	0.00129	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CNR1—metabolic syndrome X	0.000925	0.00127	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCL5—metabolic syndrome X	0.00092	0.00126	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—AGT—metabolic syndrome X	0.000918	0.00126	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000917	0.00126	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—APOC3—metabolic syndrome X	0.000865	0.00119	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—AGT—metabolic syndrome X	0.000847	0.00116	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HTR2C—metabolic syndrome X	0.000846	0.00116	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CCL2—metabolic syndrome X	0.000836	0.00115	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—AGT—metabolic syndrome X	0.000834	0.00114	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CYBA—metabolic syndrome X	0.00082	0.00112	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—GHRL—metabolic syndrome X	0.000802	0.0011	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HTR2C—metabolic syndrome X	0.000781	0.00107	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AGT—metabolic syndrome X	0.00077	0.00105	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CNR1—metabolic syndrome X	0.00076	0.00104	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IGF2—metabolic syndrome X	0.000756	0.00104	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CYBA—metabolic syndrome X	0.000756	0.00104	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—GHRL—metabolic syndrome X	0.00074	0.00101	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—APOB—metabolic syndrome X	0.000734	0.00101	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCL5—metabolic syndrome X	0.000717	0.000983	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000714	0.000979	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—LPL—metabolic syndrome X	0.000701	0.000961	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CNR1—metabolic syndrome X	0.000701	0.000961	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCL2—metabolic syndrome X	0.000687	0.000941	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCL2—metabolic syndrome X	0.000634	0.000869	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IGF2—metabolic syndrome X	0.000621	0.000852	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—APOB—metabolic syndrome X	0.000603	0.000827	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AGT—metabolic syndrome X	0.0006	0.000822	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCL5—metabolic syndrome X	0.000589	0.000807	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—APOE—metabolic syndrome X	0.000588	0.000806	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—LEP—metabolic syndrome X	0.000588	0.000806	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000587	0.000804	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—APOA1—metabolic syndrome X	0.000581	0.000796	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—LPL—metabolic syndrome X	0.000576	0.000789	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IGF2—metabolic syndrome X	0.000573	0.000786	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—APOB—metabolic syndrome X	0.000557	0.000763	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCL5—metabolic syndrome X	0.000543	0.000745	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000541	0.000742	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—LPL—metabolic syndrome X	0.000531	0.000728	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IRS1—metabolic syndrome X	0.000524	0.000719	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—INS—metabolic syndrome X	0.000502	0.000688	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCL2—metabolic syndrome X	0.000494	0.000677	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AGT—metabolic syndrome X	0.000493	0.000675	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IGF1—metabolic syndrome X	0.000486	0.000666	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—LEP—metabolic syndrome X	0.000483	0.000662	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—APOE—metabolic syndrome X	0.000483	0.000662	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—APOA1—metabolic syndrome X	0.000477	0.000654	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000461	0.000632	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AGT—metabolic syndrome X	0.000455	0.000623	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—LEP—metabolic syndrome X	0.000445	0.000611	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—APOE—metabolic syndrome X	0.000445	0.000611	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NOS3—metabolic syndrome X	0.00044	0.000604	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—APOA1—metabolic syndrome X	0.00044	0.000604	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IRS1—metabolic syndrome X	0.000431	0.00059	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—INS—metabolic syndrome X	0.000412	0.000565	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCL2—metabolic syndrome X	0.000406	0.000556	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IGF1—metabolic syndrome X	0.000399	0.000547	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IRS1—metabolic syndrome X	0.000397	0.000545	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—INS—metabolic syndrome X	0.000381	0.000522	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000379	0.000519	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000377	0.000517	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCL2—metabolic syndrome X	0.000374	0.000513	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6—metabolic syndrome X	0.000371	0.000509	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IGF1—metabolic syndrome X	0.000368	0.000505	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NOS3—metabolic syndrome X	0.000362	0.000496	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SERPINE1—metabolic syndrome X	0.00035	0.000479	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—AKT1—metabolic syndrome X	0.000343	0.00047	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOS3—metabolic syndrome X	0.000334	0.000457	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—AKT1—metabolic syndrome X	0.00031	0.000425	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—metabolic syndrome X	0.000305	0.000418	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFB1—metabolic syndrome X	0.000291	0.000399	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000286	0.000392	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—metabolic syndrome X	0.000281	0.000386	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—AKT1—metabolic syndrome X	0.000281	0.000386	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AKT1—metabolic syndrome X	0.00026	0.000356	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFB1—metabolic syndrome X	0.000239	0.000328	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFB1—metabolic syndrome X	0.000221	0.000302	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—metabolic syndrome X	0.000219	0.000301	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKT1—metabolic syndrome X	0.000202	0.000277	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—metabolic syndrome X	0.00018	0.000247	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—metabolic syndrome X	0.000166	0.000228	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKT1—metabolic syndrome X	0.000166	0.000228	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKT1—metabolic syndrome X	0.000153	0.00021	CbGpPWpGaD
